Today
Apex Critical Metals Corp Apex Announces Brokered LIFE Offering of up to $10,001,600
24 minutes ago
Permian Basin Royalty Trust SoftVest and Blackbeard Holdings Announce Proposed Business Combination with Permian Basin Royalty Trust
24 minutes ago
Four Corners Property Trust, Inc. FCPT Announces Acquisition of a BJ's Restaurant and Brewhouse Property for $4.6 Million
24 minutes ago
Northern Trust Corporation Northern Trust Leaders to Participate in Morgan Stanley 2026 US Financials Conference on June 9
24 minutes ago
Pennant Group to Participate in the 2026 RBC Global Healthcare Conference
25 minutes ago
KBRA Assigns Preliminary Rating to MRE 2026-1
25 minutes ago
Medline deploys new AutoStore installation at distribution center in Aurora, Colorado
an hour ago
EVA Air Wins SKYTRAX 5-Star Airline Certification 11th Year in a Row
an hour ago
Granite Construction Incorporated Granite Construction Incorporated Prices $600 Million Senior Notes Offering
an hour ago
Visa and Jason Sudeikis Turn the Simplest Goal in Football Into the Biggest Fan Moments at the FIFA World Cup 2026™
an hour ago
Intuitive Machines Announces Two Prime Lunar Reconnaissance Contracts
an hour ago
Evertec Signs Strategic Agreement with Transbank
an hour ago
John Stankey to Update Shareholders at J.P. Morgan Global Technology, Media and Communications Conference on May 19
an hour ago
Babcock & Wilcox Enterprises, Inc. Babcock & Wilcox Enterprises Announces Closing of Common Stock Offering
an hour ago
Pennant Announces an Acquisition of Senior Living Community in Arizona
an hour ago
TrendAI™ Zero Day Initiative Leads Industry Remediation at Pwn2Own Berlin
an hour ago
MediaCo Reports First Quarter Financial Results
an hour ago
Cullinan Therapeutics, Inc. Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress
an hour ago
SSR Mining Announces the Sale of Its 20% Equity Interest in Hod Maden
an hour ago
Telix Pharmaceuticals Limited IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
an hour ago